Focused Ultrasound Provides Lasting Relief for Parkinson's Motor Symptoms

Results from a pivotal Phase III clinical trial confirm that staged bilateral MR-guided focused ultrasound (MRgFUS) significantly and durably improves motor symptoms in Parkinson's disease patients. The study, published in The Lancet Neurology, showed substantial improvement in motor complications and dyskinesia, with benefits sustained for at least 12 months. This offers a promising treatment option for individuals with the condition.